Spire Wealth Management Reata Pharmaceuticals Inc Transaction History

Spire Wealth Management

  • $2.95 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 18, 2022
SELL
$24.12 - $39.6 $12,060 - $19,800
-500 Closed
0 $0
Q4 2021

Jan 14, 2022
BUY
$25.61 - $110.96 $12,805 - $55,480
500 New
500 $13,000
Q2 2021

Jul 26, 2021
SELL
$78.27 - $151.29 $60,267 - $116,493
-770 Closed
0 $0
Q1 2021

May 21, 2021
BUY
$94.25 - $132.81 $72,572 - $102,263
770 New
770 $75,000

Others Institutions Holding RETA

# of Institutions
5
Shares Held
62.7K
Call Options Held
0
Put Options Held
0
View Full List

About REATA PHARMACEUTICALS INC

RETA Quotes by TradingView
  • Ticker RETA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 31,583,200
  • Description
  • Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...
More about RETA
Track This Portfolio

Track Spire Wealth Management Portfolio

Follow Spire Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Spire Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Spire Wealth Management with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email